Northern Arizona Radiology in Flagstaff, Ariz., recently became the first healthcare facility in the United States to adopt the MAGNETOM Altea 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) scanner from Siemens Healthineers.
In addition to a wide, 70cm bore, the MAGNETOM Altea possesses several industry-leading technologies, including BioMatrix patient personalization technology with the Select&GO Interface, which removes the need for anatomical landmarking to enable faster patient positioning. Additionally, Dot (Day Optimizing Throughput) technology automates the exam to support standardized, highly reproducible scan procedures. To accelerate routine examinations, Turbo Suite offers customized speed applications covering various areas of the body to reduce scan time by up to 50 percent without compromising image quality.
"Siemens Healthineers is pleased to provide Northern Arizona Radiology with the MAGNETOM Altea, which features BioMatrix patient personalization technology that will help transform care delivery in radiology by providing consistent quality while improving patient satisfaction and workflow optimization," said Jane Kilkenny, Vice President of the Magnetic Resonance business at Siemens Healthineers North America.
Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.
"The MAGNETOM Altea MRI scanner provides state-of-the-art capabilities in musculoskeletal, neurological, cardiac, and oncologic imaging, and expands the capabilities available to patients in Northern Arizona," said James Skrocki, MD, radiologist, Northern Arizona Radiology.
Siemens Healthineers AG (listed in Frankfurt, Germany, DE:SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers' worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.
Further information is available at www.siemens-healthineers.com.